Frontiers | Targeting BCMA to Treat Multiple Myeloma: Updates …
https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.839097/full
WEBMar 6, 2022 · B-cell maturation antigen (BCMA/CD269), which belongs to TNF receptor superfamily member 17 ( 5 ), is highly selectively expressed on the surface of MM cells, as the ideal target of majority targeted agents studied currently for the patients with MM ( 6 ), such as anti-BCMA mAbs, antibody-drug conjugates (ADCs), bispecific T-cell engagers …
DA: 65 PA: 61 MOZ Rank: 37